Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Charles Carlson Highlights the Following Stock: Bristol-Myers Squibb.


Business Editors

CHICAGO--(BUSINESS WIRE)--Jan. 31, 2003

DRIP investors will have plenty of opportunities for profit if the double taxation of dividends is terminated. Now is a good time to get acquainted with this investment style, and market expert Charles Carlson is here to explain the ins and outs ins and outs  
pl.n.
1. The intricate details of a situation, decision, or process.

2. The windings of a road or path.
, along with a stock suggestion on Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were  (NYSE NYSE

See: New York Stock Exchange
:BMY BMY Bristol Myers Squibb ) for starters. Click here for the full story exclusively on Zacks.com: http://featuredexpert2bw.zacks.com/

Here are the highlights from the Featured Expert column:

As you can imagine, Charles Carlson has been fielding lots of calls from the media looking for Looking for

In the context of general equities, this describing a buy interest in which a dealer is asked to offer stock, often involving a capital commitment. Antithesis of in touch with.
 comments on the president's tax plan as it relates to DRIPs. His answer? This is good news for DRIP investors. The tax plan would induce more companies to initiate dividends, which would likely increase the number of companies implementing DRIPs. Furthermore, the tax plan enhances the attractiveness of dividend- paying stocks, which enhances the investment appeal of many companies that offer DRIPs.

If Carlson could pick only one of the "crash" stocks from the portfolio to buy for the next 12 months, he would choose Bristol-Myers Squibb (NYSE: BMY). He likes the stock's yield of well over 4%, and the president's proposed tax plan should make high-yielding stocks such as Bristol-Myers Squibb even more attractive. He also believes you will see better performance from drug stocks in general in 2003, which should help Bristol-Myers Squibb.

Learn much more about the President's tax plan and get Charles Carlson's inside scoop on DRIPs and DRIP investing by clicking: http://featuredexpert3bw.zacks.com/

About Zacks Featured Experts

To be a successful investor you need professional advice. Experts who know what they're talking about and can help you achieve your financial goals in good markets...and especially in bad ones will help you improve your portfolio. That is why Zacks Investment Research Zacks Investment Research

A firm that compiles earnings estimates and brokerage firm investment recommendations for thousands of publicly traded firms.
 has assembled the best investment experts in the business to offer their powerful advisory newsletters to you on all the major investment topics: Stocks, Mutual Funds, Bonds, Options, Futures etc.

Recommendations from Featured Experts Highlighted in FREE Investment Newsletter

The best way to tap into the powerful advice from these experts is through our free weekly e-mail newsletter, "Profit from the Pros". Each week we highlight several Featured Experts in this free e-mail See Internet e-mail service.  newsletter. Get your free subscription to "Profit from the Pros" at: http://www.freeprofit1bw.zacks.com

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1981 to compile To translate a program written in a high-level programming language into machine language. See compiler. , analyze, and distribute investment research to both institutional and individual investors. The guiding principle behind our work is the belief that investment experts, such as brokerage analysts and investment newsletter writers, have superior knowledge about how to invest successfully. Our goal is to unlock their profitable insights for our customers. And there is no better way to enjoy this investment success, than with a FREE subscription to "Profit from the Pros" weekly e-mail newsletter. For your free newsletter, visit http://www.freeprofitbw.zacks.com

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer (networking) disclaimer - Statement ritually appended to many Usenet postings (sometimes automatically, by the posting software) reiterating the fact (which should be obvious, but is easily forgotten) that the article reflects its author's opinions and not necessarily those of the : Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation solicitation

In criminal law, the act of asking, inducing, or directing someone to commit a crime. The person soliciting another becomes an accomplice to the crime. The term also refers to the act of obtaining bribes, as well as to the crime of a prostitute who offers sexual
 to buy or sell any security.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 31, 2003
Words:569
Previous Article:Simsbury Bank Reports 53% Earnings Growth for 2002.
Next Article:Richard Moroney Recommends the Following Stocks: Centene and Immucor.



Related Articles
AIDS drug sparks concern.
Bristol-Myers hires project mgr.
Looting the medicine chest: how Bristol-Myers Squibb made off with the public's cancer research.
Two Tower Center is a towering success.
d4T plus ddl: Warning for Pregnant Women.
Points of light: Daily award highlights volunteers. (Award Winners).
States join fight against drug companies for keeping generics off the market.
Analysis equals performance: Charles Payne of Wall Street Strategies uses three critical measures to select winners.
Squibb complex sold, leased back.
Lawsuits question safety and efficacy of Plavix.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles